Vitreoretinal surgery is among the most technically demanding disciplines in all of ophthalmology. Operating on the retina, the paper-thin layer of light-sensitive tissue lining the back of the eye, requires surgeons to manipulate instruments within a space smaller than a ping-pong ball, often working at magnifications of twenty-five times or more under an operating microscope. Procedures such as vitrectomy, membrane peeling, and the repair of retinal detachments demand millimeter-precision movements, where a tremor of even a fraction of a millimeter can mean the difference between restored vision and permanent damage. Because of this unforgiving learning curve, surgical educators have traditionally leaned toward observation-based models, particularly in programs that employ dedicated retina fellows who take priority in the operating room.

The new research, led by Jin Kyun Oh and Tarun Sharma of the Harkness S. Eye Institute at Columbia, was conducted at NYC Health + Hospitals/Harlem between April 15, 2024, and March 30, 2025. The team carried out a single-center retrospective observational study in which eight ophthalmology residents participated in thirty retinal surgeries under direct faculty supervision. Rather than standing at the edge of the operating theater as passive observers, the residents were placed in the surgeon’s seat for defined portions of each case, with attending surgeons guiding every step. A structured questionnaire then captured which surgical steps each resident performed, how much they felt their skills had improved, the quality of their mentorship experience, and the barriers that had previously limited their surgical training.

The results were striking in their consistency. Every one of the eight residents reported moderate to significant improvement in surgical skills and in their understanding of retinal pathoanatomy, the structural changes that disease produces in the retina. Participation in key surgical steps increased substantially over the course of the rotation, indicating that the more the residents operated, the more responsibility their mentors entrusted to them. Surgical mentorship was universally rated as excellent, a detail that the authors highlight as central to the model’s success. All residents also affirmed the educational value of preoperative fundus drawings, detailed sketches of the retina made before surgery that force the trainee to study the pathology and plan the operation in advance.

Those fundus drawings deserve particular attention, because they embody a teaching principle that extends far beyond the operating room. Before a vitreoretinal procedure, the surgeon maps out the location of retinal tears, detachments, membranes, and other pathology on a paper diagram. For a resident, producing this drawing is not a clerical chore but a cognitive exercise: it requires interpreting imaging studies, correlating them with the clinical examination, and mentally rehearsing the sequence of surgical maneuvers needed to address each finding. By the time the patient is under anesthesia, the resident has already performed the operation once in their mind, a form of deliberate practice that cognitive scientists associate with durable skill acquisition.

The technical steps that residents performed during the study span the core repertoire of vitreoretinal surgery. In a typical vitrectomy, the surgeon first creates three small ports in the sclera, the white outer coat of the eye, to introduce a cutting instrument that removes the vitreous gel filling the eye’s interior. Subsequent steps may include inducing a posterior vitreous detachment to separate the gel from the retina, peeling epiretinal membranes with fine forceps, applying laser photocoagulation to seal retinal tears, and injecting gas or silicone oil to tamponade the retina in place while it heals. Each of these maneuvers rewards repetition, and the study’s finding that resident participation increased substantially during the rotation reflects the graduated autonomy that defines effective surgical apprenticeship: as competence grows, so does the share of the operation the trainee performs.

Yet the study is equally candid about the obstacles that keep residents away from the retina. The most commonly cited barriers were clinical responsibility, the competing demands of ward and clinic duties that eat into operating time, and the presence of fellows at other sites, which diverts surgical cases to advanced trainees ahead of residents. This structural competition is a well-known feature of American ophthalmology training. Programs with their own retina fellows often relegate residents to the observation deck, reasoning that fellows need the volume to become independent retina surgeons. The Columbia-Harlem model demonstrates that this either-or framing is false: with structured mentorship and deliberate case allocation, residents can gain meaningful operative experience without compromising fellow education or patient safety.

The educational stakes are considerable. Vitreoretinal disease, including diabetic retinopathy, retinal detachment, and age-related macular degeneration, is a leading cause of vision loss worldwide, and the demand for retina surgeons continues to outpace supply. Residents who graduate without operative confidence in retinal surgery face a steeper path to fellowship and independent practice, and communities served by general ophthalmologists may lack access to timely surgical care. The authors argue that direct hands-on participation, combined with structured mentorship and preoperative planning, may serve as a replicable model to improve vitreoretinal surgical education nationally, a claim that carries weight given that the study took place at a public hospital serving a diverse urban population rather than at an elite private center.

The study’s design does impose limits on how far its conclusions can be stretched. As a retrospective observational study with eight residents at a single center, it relies on self-reported perceptions of skill improvement rather than objective assessments by blinded raters, and it lacks a comparison group of residents trained under the traditional observation model. Still, the uniformity of the responses is difficult to dismiss: when all participants independently report substantial gains and rate mentorship as excellent, the signal is strong enough to justify broader testing. The work received an ethics exemption from Columbia’s Institutional Review Board and was funded in part by Research to Prevent Blindness unrestricted funds to the Department of Ophthalmology.

What makes the study resonate beyond ophthalmology is the simplicity of its prescription. Surgical education across specialties has long wrestled with the tension between patient safety and trainee autonomy, and the default solution has too often been observation. The Columbia-Harlem experience shows that the alternative, placing residents in the surgeon’s seat for defined steps under vigilant supervision, beginning with meticulous preoperative planning, and scaling responsibility as competence grows, is both safe and transformative. For the residents of Harlem, thirty operations did more than teach surgical technique; they converted spectators into participants, and participants, the evidence suggests, into surgeons ready to carry the specialty forward.

Subject of Research: Medical Education

Article Title: Enhancing resident education through active participation in vitreoretinal surgery

Article References: Oh, J. K., Li, C. Y., Kassotis, A., Gu, S. Z., Moussa, O., Shabto, J. M., Yu, S. N., Hirji, S. H., & Sharma, T. (2026). Enhancing resident education through active participation in vitreoretinal surgery. BMC Medical Education. https://doi.org/10.1186/s12909-026-10634-8

Image Credits: AI Generated

DOI: 10.1186/s12909-026-10634-8

Keywords: vitreoretinal surgery, ophthalmology, resident education, surgical training, medical education, retina, mentorship, Enhancing, resident, education, active, participation

The review builds on the American Heart Association’s cardiovascular–kidney–metabolic (CKM) framework, which recognizes that metabolic dysfunction, kidney injury and cardiovascular disease form an interconnected continuum rather than isolated conditions. Obesity, insulin resistance and type 2 diabetes set off a cascade of vascular damage that simultaneously attacks the heart, the kidneys and the brain. Yet the authors point out that the brain — and the central nervous system more broadly — remains insufficiently integrated into this paradigm. To close that gap, they adopt an expanded analytical framework they call cardiovascular–kidney–brain–metabolic syndrome (CKBMS). Importantly, they are not proposing a new diagnostic label; rather, CKBMS serves as an operational lens for examining how microvascular dysfunction, endothelial injury and impairment of the neurovascular unit may link damage across all three organ systems in the context of metabolic dysregulation.

Why the retina? The answer lies in its remarkable anatomy. The retina shares key structural and functional features with the heart, kidneys and brain: it hosts a dense microvascular network, relies on delicate barrier architecture (the blood–retinal barrier mirrors the blood–brain barrier), and contains neural tissue that can be imaged directly. In fact, the retina is the only place in the human body where clinicians can non-invasively visualize both microvasculature and neural tissue in vivo. Retinal vessels and cerebral vessels share similar embryological origins, size ranges and autoregulatory mechanisms, making the eye a plausible surrogate for what is happening in the brain’s smallest blood vessels — and, by extension, in the microcirculation of the kidneys and heart.

The technical toolkit for reading these signals has expanded dramatically. Color fundus photography, the workhorse of retinal imaging, captures vascular geometry: arteriovenous ratio, fractal dimension (a measure of vascular branching complexity), and calibers summarized as central retinal arteriolar and venular equivalents. Narrower arterioles, wider venules and simplified branching patterns have all been linked, in large cohort studies, to elevated blood pressure burden, incident cardiovascular events and renal function decline. Optical coherence tomography (OCT) adds a structural dimension, quantifying retinal nerve fiber layer thickness and ganglion cell–inner plexiform layer volume — neural metrics that thin when neurodegeneration strikes. Optical coherence tomography angiography (OCTA), a newer dye-free technique, maps perfusion at the capillary level, quantifying vessel density in distinct vascular plexuses and the size of the foveal avascular zone. In diabetic retinopathy research, OCTA-derived deep capillary plexus measures have emerged as particularly sensitive markers of early microvascular injury.

The evidence connecting these retinal phenotypes to systemic disease is accumulating across multiple organ fronts. Retinal vascular narrowing and venular widening correlate with blood pressure burden and predict major adverse cardiovascular events in population cohorts. In kidney disease, retinal arteriolar damage tracks with estimated glomerular filtration rate decline and albumin-to-creatinine ratio elevation, with diabetic kidney disease showing especially strong retinal–renal concordance. In the brain, retinal vessel changes associate with cerebral small vessel disease — white matter hyperintensities, lacunar infarcts and cerebral microbleeds visible on MRI — and with cognitive impairment, including vascular cognitive impairment and Alzheimer’s disease. Shared mechanisms likely underlie these correlations: chronic hyperglycemia generates advanced glycation end products that stiffen basement membranes, endothelial dysfunction promotes barrier breakdown, and renin–angiotensin system overactivity drives vasoconstriction across all affected beds.

Deep learning is the engine transforming this field from qualitative observation to quantitative risk modeling. Convolutional neural networks now extract vascular topology and subtle imaging features that escape human graders, while multimodal deep learning fuses retinal data with clinical variables to predict multi-organ outcomes. The review highlights systems such as the Singapore

The review’s authors are careful to position retinal imaging as an adjunct rather than a replacement for established clinical assessment. They emphasize that current evidence supports its role as a source of complementary risk phenotypes and an adjunctive stratification tool — not as a stand-alone modality for diagnosis or disease staging, and not as a substitute for specialist cardiovascular, nephrological, or neurological evaluation. This framing matters because retinal findings, while statistically associated with systemic outcomes in population studies, do not yet carry the predictive precision required for individual clinical decisions. Associations reported across cohorts vary in strength, and the review repeatedly stresses the need to weigh evidence quality against methodological limitations before translating research findings into practice.

Those methodological limitations form a substantial part of the critical appraisal. Many of the studies linking retinal metrics to cardiovascular, renal, and cerebral outcomes are cross-sectional or rely on retrospective cohorts, which limits causal inference. Measurement variability poses another challenge: retinal vascular calibers and perfusion parameters can be influenced by image quality, acquisition protocols, and grading software, and different quantitative tools — such as the Singapore “I” Vessel Assessment, Integrative Vessel Analysis, Vascular Assessment and Measurement Platform for Images of the Retina, and QUantitative Analysis of Retinal vessel Topology and size — do not always produce interchangeable values. Confounding is a persistent concern as well, since age, blood pressure, glycemic control, and medication use simultaneously shape both retinal appearance and systemic disease trajectories. The authors also note that much of the evidence base derives from populations of European and Asian ancestry, raising questions about generalizability to other groups.

To move the field forward, the review calls for prospective, multicenter, cross-device studies designed to validate the incremental clinical value of retinal imaging over conventional risk assessment strategies. Such studies would need to demonstrate that adding retinal phenotypes to existing risk models — which already incorporate age, blood pressure, lipid profiles, glycemic status, and renal function — meaningfully improves risk discrimination, typically measured by area under the receiver operating characteristic curve, or reclassifies patients in clinically useful ways. Standardization of image acquisition and analysis pipelines across devices and centers will be essential, since deep learning models trained on one scanner or population often degrade when deployed in new settings.

The appeal of retinal imaging as a population screening tool is nonetheless considerable. Fundus photography is fast, inexpensive, and already widely deployed in diabetic eye screening programs around the world, meaning the infrastructure for large-scale retinal image capture largely exists. OCT and OCTA are increasingly common in ophthalmology clinics, and their outputs — retinal nerve fiber layer thickness, ganglion cell–inner plexiform layer volume, vessel density in the superficial and deep capillary plexuses, and foveal avascular zone area — can be quantified automatically. If deep learning systems can reliably extract systemic risk signals from these routine scans, a single imaging session could, in principle, serve double duty: monitoring eye health while simultaneously contributing to cardiovascular, renal, and cognitive risk stratification. This would be particularly valuable in primary care settings and in regions where specialist access is limited, since metabolic diseases and their complications are rising fastest in low- and middle-income countries.

The mechanistic rationale connecting the eye to the kidney deserves particular attention. Both organs share remarkably similar microvascular architecture: the glomerular filtration barrier of the kidney and the blood–retinal barrier of the eye both depend on fenestrated endothelia, basement membranes, and supporting cells — podocytes in the kidney, Müller cells and pericytes in the retina — that are vulnerable to the same metabolic insults. Advanced glycation end products cross-link basement membrane proteins in both tissues, and hyperglycemia-driven pericyte loss is a hallmark of both diabetic retinopathy and diabetic kidney disease. This structural and biochemical parallelism helps explain why retinal arteriolar narrowing tracks with estimated glomerular filtration rate decline and albumin-to-creatinine ratio elevation, and why the concordance between retinal and renal findings is strongest in diabetic kidney disease. It also suggests that retinal imaging could serve as a repeatable, non-invasive readout of microvascular health in organs that cannot be directly visualized without biopsy or contrast-based imaging.

On the cerebral side, the neurovascular unit concept provides a unifying framework. The neurovascular unit comprises neurons, glial cells, vascular cells, and the extracellular matrix that together maintain the blood–brain barrier and couple blood flow to neural activity. Metabolic dysregulation disrupts this unit through endothelial injury, chronic inflammation — signaled by elevated interleukin-6 and tumor necrosis factor-α — and renin–angiotensin system overactivity. Because retinal vessels share embryological origins, size ranges, and autoregulatory behavior with cerebral vessels, retinal vascular geometry may reflect the state of cerebral small vessels that are themselves inaccessible to direct imaging except through MRI. The observed associations between retinal vessel changes and white matter hyperintensities, lacunar infarcts, and cerebral microbleeds are consistent with this shared-vulnerability model, although the review is careful to note that correlation does not establish that retinal imaging can predict cerebral outcomes at the individual level.

Ultimately, the review charts a measured course between enthusiasm and caution. The convergence of mature imaging infrastructure, quantitative biomarkers, and deep learning analysis tools has created a genuine opportunity to repurpose a routine ophthalmic examination as a systemic health screen. But the authors’ central message is that the science is not yet settled: the field needs rigorous, prospective validation across diverse populations and devices before retinal imaging can claim a defined role in clinical risk management. If those validation efforts succeed, the humble eye examination — long valued for its own sake — may take on an expanded role as a routine, non-invasive checkpoint for the vascular health of the heart, kidneys, and brain.

Subject of Research: The retina as a window to systemic health: non-invasive imaging biomarkers for cardiovascular–kidney–brain risk in metabolic disease

Article Title: The retina as a window to systemic health: non-invasive imaging biomarkers for cardiovascular–kidney–brain risk in metabolic disease

Article References: Ma, X., Yu, Q., Wei, L., Chen, Z., Ma, Z., Lai, T., Zheng, M., Gu, C., & Rao, H. (2026). The retina as a window to systemic health: non-invasive imaging biomarkers for cardiovascular–kidney–brain risk in metabolic disease. Journal of Translational Medicine. https://doi.org/10.1186/s12967-026-09058-1

Image Credits: AI Generated

DOI: 10.1186/s12967-026-09058-1

Keywords: retina, window, systemic, health, non-invasive, imaging, biomarkers, cardiovascular, kidney, brain, risk, metabolic

What makes the current findings noteworthy is the direction of the change. In many neurodegenerative conditions, OCT studies report thinning of the nerve fiber layer and ganglion cell complex, reflecting loss of neurons and their axons. In patients with Steinert disease, the study found a generalized thickening of retinal layers instead, together with significant thickening of the retinal nerve fiber layer in the temporal region of the optic nerve and in the papillomacular bundle. Thickening rather than thinning suggests that the pathological process in the retina of these patients may not be straightforward degeneration. Several mechanisms could theoretically produce increased retinal thickness, including intraretinal edema, accumulation of metabolic byproducts, altered cellular metabolism, gliosis involving Müller cells or astrocytes, or changes in axonal transport. Myotonic dystrophy type 1 is caused by toxic gain-of-function RNA from the expanded CTG repeat, which sequesters RNA-binding proteins and disrupts alternative splicing of many target genes. Because those splicing factors are active in multiple tissues, including neural and retinal tissue, the same molecular mechanism that produces myotonia in skeletal muscle could plausibly disturb cellular homeostasis in the retina, and the observed structural changes may reflect that disturbance rather than simple cell loss.

The papillomacular bundle deserves particular attention. This bundle contains the ganglion cell axons that run from the macula, the region responsible for central and high-acuity vision, to the optic disc, and it is known to be selectively vulnerable in several neurological disorders, including mitochondrial disease and dominant optic atrophy. The finding of significant RNFL thickening specifically in this bundle, detected with the aid of fovea-to-disc technology that aligns the scan to each patient’s individual anatomy, suggests a patterned rather than random involvement of the retinal nerve fiber layer. Patterned involvement is generally more informative than diffuse change because it can point to the underlying distribution of pathology. If future studies confirm that the papillomacular bundle is consistently affected in Steinert disease, this sector could serve as a region of interest in longitudinal monitoring, in the same way that specific peripapillary sectors are used to track glaucomatous progression.

The methodological choices in this study strengthen the reliability of its conclusions. Selecting only one eye per participant is an important safeguard, because the two eyes of a single individual are highly correlated in both anatomy and disease expression, and treating them as independent observations can artificially inflate statistical significance. Excluding eyes with axial lengths outside the range of 22.1 to 25.2 millimeters and refractive errors of five diopters or more of spherical equivalent controls for a well-known confounder, since axial elongation stretches the retina and thins many of its layers independently of any disease process. Restricting inclusion to patients with minimal lens opacity, scored 0 or 1 on the Lens Opacities Classification System III, reduces the risk that cataract-related signal degradation would distort the OCT segmentation. This last point is particularly relevant to Steinert disease, because cataracts are present in nearly all patients with the condition and could otherwise contaminate retinal measurements. Perhaps most importantly, the exclusion of eyes with epiretinal membranes and macular edema distinguishes this study from much of the earlier literature, in which such concomitant pathologies were often present and may have driven the retinal changes attributed to the disease itself.

The two imaging protocols used here complement each other in a useful way. The posterior pole protocol divides a 25 by 30 degree area of the macula into an 8 by 8 grid of 64 cells, each approximately one square millimeter, and segments eight distinct layers in every cell. This dense sampling allows localized changes to be detected that would be averaged away in a single global measurement. The Anatomic Positioning System corrects for head tilt and cyclotorsion of the eye by referencing a horizontal line between the fovea and the opening of Bruch’s membrane, ensuring that the grid is aligned consistently across patients and visits. The Nsite analytics module, in contrast, focuses on the peripapillary nerve fiber layer and divides it into six sectors, using the same fovea-to-disc alignment to standardize the position of the papillomacular bundle analysis. Together, these protocols cover both the macular and peripapillary territories, which is valuable because different diseases affect these regions differently; for example, ganglion cell involvement often shows first in the macula, while axonal changes may appear earlier around the disc.

The sample sizes, 79 eyes from 79 patients with genetically confirmed disease and 128 control eyes for the posterior pole analysis, are respectable for a study of a relatively rare condition. Myotonic dystrophy type 1 is the most common muscular dystrophy affecting adults, with an estimated prevalence in the range of one in several thousand in European populations, yet recruitment remains challenging because affected individuals may have limited mobility and because the clinical presentation varies widely with the size of the CTG repeat expansion. Larger repeat expansions are generally associated with earlier onset and more severe disease, a phenomenon known as anticipation, in which the repeat length can increase across generations. This heterogeneity means that future studies correlating retinal measurements with repeat length, age at onset, or the severity of muscle weakness and myotonia would need to account for these variables explicitly, and the present cross-sectional design was not powered to establish such correlations.

The authors are appropriately cautious on this point. No conclusive evidence currently links the retinal findings to the severity of neuromuscular symptoms, and the study does not claim that OCT measurements can substitute for neurological assessment. What the results do establish is that retinal structural alterations are present in patients with Steinert disease even when confounding ocular pathologies are excluded, and that these alterations are detectable with standard commercial OCT protocols. This opens several lines of future investigation. Longitudinal studies could determine whether retinal layer thickness changes over time and whether the rate of change relates to disease progression elsewhere. Correlation studies could test whether retinal measures track with markers of central nervous system involvement, such as cognitive testing or neuromuscular scores. The observation that the retina may reflect involvement of the broader nervous system is consistent with the multisystemic character of myotonic dystrophy, in which the central nervous system is affected in many patients, producing features such as cognitive impairment, excessive daytime sleepiness, and apathy.

From a clinical standpoint, the findings support the inclusion of routine ophthalmological evaluation in the care of patients with Steinert disease, beyond the assessment of cataracts that is already standard practice. Patients with this condition are known to have ptosis, weakness of the extraocular muscles, slow pupillary responses, and low intraocular pressure in addition to cataracts, and the current results add retinal structural changes to this list. Because the changes were detected in patients whose lenses were nearly clear, they are unlikely to be artifacts of media opacity, and because the control group was age-matched, they are unlikely to reflect normal aging. The color maps generated by the posterior pole protocol can visualize differences of 10 to 15 micrometers, which means that even subtle changes could be followed in clinical practice if validated thresholds and progression criteria are established.

It is worth noting some limitations inherent to the study design. The cross-sectional nature of the data means that the direction of causality between the disease and the retinal changes cannot be established, although the genetic basis of Steinert disease makes the direction reasonably clear in this case. The number of control eyes available for the peripapillary Nsite analysis was smaller, 39 eyes, than for the posterior pole analysis, because the additional normative database controls lacked Nsite recordings, and this asymmetry should be kept in mind when weighing the peripapillary findings. No manual correction of the automated segmentation was applied, which preserves objectivity but means that segmentation errors, if any occurred, were not corrected; the use of an internal fixation target, which has the highest reported reproducibility, helps to minimize such errors by stabilizing fixation during acquisition. Finally, the patients were recruited at a single center in Spain, and replication in independent cohorts with different ancestries and disease durations would strengthen the generalizability of the conclusions.

In summary, this study contributes a carefully controlled characterization of retinal layer structure in type 1 myotonic dystrophy, demonstrating generalized retinal thickening and sector-specific nerve fiber layer changes in the temporal optic nerve and papillomacular bundle. The work illustrates how high-resolution, layer-specific imaging can reveal patterns of involvement in a multisystemic genetic disease and provides a foundation for the use of OCT-derived structural markers in future research on retinal and possibly central nervous system involvement in Steinert disease.

Subject of Research: Retinal layer structural changes in Steinert disease measured by optical coherence tomography

Article Title: Structural changes in the retinal layers of patients with Steinert disease

Article References: Cordón, B., Pardiñas, B., Hernández, M., Rodrigo, M. J., Mayordomo, E., Pablo, L. E., & García-Martin, E. (2026). Structural changes in the retinal layers of patients with Steinert disease. Frontiers in Ophthalmology, 6, Article 1959492. https://doi.org/10.3389/fopht.2026.1959492

Image Credits: AI Generated

DOI: 10.3389/fopht.2026.1959492

Keywords: Steinert disease, myotonic dystrophy type 1, optical coherence tomography, retinal layers, retinal nerve fiber layer, papillomacular bundle, neuro-ophthalmology, retina, biomarkers, DMPK gene, Structural, changes

The finding is all the more compelling because it emerged from a statistical landscape riddled with contradiction. When the researchers combined crude, cross-sectional comparisons of cognitive impairment between patients with and without retinopathy, the association essentially vanished, yielding a pooled odds ratio of 1.07 with a confidence interval that comfortably included the null. Yet when they turned to longitudinal studies that tracked incident dementia over follow-up periods ranging from roughly four to nearly sixteen years, a different picture emerged: diabetic retinopathy was associated with a 55 percent higher incidence of dementia, with a hazard ratio of 1.55 and a p-value of 0.001. The temporal distinction, the authors argue, is the key. Retinopathy may not simply coexist with cognitive decline; it may precede it, functioning as a prognostic marker for future deterioration.

That interpretation rests on a conceptual shift that has been gathering momentum in ophthalmology and neuroscience alike. Diabetic retinopathy was once classified purely as a microvascular complication, the consequence of chronically elevated glucose damaging the delicate capillaries of the retina. But imaging and electrophysiological studies have revealed that the disease is also neurodegenerative. Inner retinal thinning, depletion of retinal ganglion cells, reactive gliosis, and functional deficits measurable by electroretinogram all appear before clinically detectable microvascular lesions. In other words, the diabetic eye begins to lose neurons before it begins to leak. Early impairment of the neurovascular unit, evidenced by diminished vasomotor responses to hyperoxic and flickering light stimuli, mirrors the neurovascular dysfunction observed in cerebral pathologies such as stroke and Alzheimer’s disease.

The parallels extend deep into the brain itself. Neuroimaging studies have shown that type 2 diabetes is associated with brain atrophy, particularly in the hippocampus and temporal lobe, along with a higher burden of small infarcts and white matter hyperintensities. Functional imaging reveals disrupted neural signaling in regions responsible for emotion and cognition, including the frontal lobe and amygdala, even in the early stages of cognitive decline. Against this backdrop, the retina, which shares its embryological origin with the cerebral blood barriers, becomes a plausible sentinel: accessible, photographable, and structurally akin to the tissue it mirrors.

The mechanistic hypotheses underpinning this link are as varied as they are tantalizing. Hyperglycemia-driven endothelial dysfunction, oxidative stress, inflammation, vascular endothelial growth factor signaling, and the accumulation of advanced glycation end products have all been proposed as processes that damage both retinal and cerebral neurovascular tissues. Elevated serum levels of advanced glycation end products have been documented in diabetic patients with mild cognitive impairment, and their receptors, once engaged, activate nuclear factor kappa B in neurovascular tissues of both the retina and the brain, amplifying oxidative stress and inflammation. A separate line of reasoning implicates the hyperinsulinemic state of early type 2 diabetes: high insulin levels consume insulin-degrading enzyme, the very enzyme responsible for clearing amyloid-beta, potentially accelerating the formation of the senile plaques that define Alzheimer’s pathology.

Perhaps the most intriguing hypothesis concerns tau. Glycogen synthase kinase 3 beta, an enzyme whose activity is heightened in diabetes, phosphorylates tau protein, and in patients with diabetic retinopathy this hyperphosphorylated tau contributes to synaptic degeneration in retinal ganglion cells before microvascular changes become visible. The same tau pathology, aggregated into neurofibrillary tangles, is a hallmark of Alzheimer’s disease in the brain. If retinal neurodegeneration truly precedes microvascular damage in the diabetic eye, as several studies suggest, then the retina may be offering clinicians a live preview of processes unfolding in the cerebral cortex.

Yet the new meta-analysis is careful to temper enthusiasm with statistical humility. The longitudinal synthesis, while statistically significant, carried an I-squared of 97.8 percent, indicating that nearly all of the variability in effect estimates across studies was attributable to heterogeneity rather than chance. The 95 percent prediction interval, spanning 0.65 to 3.68, crossed the null value, meaning that the magnitude and even the direction of the association could differ substantially in future settings. A leave-one-out sensitivity analysis confirmed that no single study drove the result, with pooled estimates ranging from 1.36 to 1.66 depending on which cohort was excluded, but the underlying diversity of populations, retinopathy definitions, dementia ascertainment methods, and adjustment strategies remains formidable.

The subtype findings are equally unsettled. Some large population-based studies, including the Atherosclerosis Risk in Communities cohort and the Cardiovascular Health Study, found that retinopathy was associated with vascular or cerebrovascular-related dementia but not with Alzheimer’s disease, a pattern consistent with the small-vessel-disease hypothesis, which holds that diabetic retinopathy is a visible marker of systemic microangiopathy affecting end organs including the brain. Conversely, two nationwide Korean cohorts reported significant associations with both Alzheimer’s disease and vascular dementia, with comparable effect sizes across subtypes. Because definitions, populations, and analytical models differed so widely, the authors declined to pool these subtype estimates, leaving the question of mechanism deliberately open.

The limitations of the evidence base are acknowledged candidly by the review team. All fourteen included studies were observational, meaning that residual and unmeasured confounding cannot be excluded, and the covariates adjusted for varied substantially from study to study. Only one study specifically evaluated type 1 diabetes, so the findings predominantly reflect type 2 disease. Inconsistent severity categories prevented a reliable dose-response analysis, and although the largest and most recent cohort, a 2025 South Korean study of more than 784,000 people, reported a hazard ratio of 2.74 for dementia among those with diabetic macular retinopathy, the pooled estimate is heavily influenced by that single outlier. Administrative coding and medical-record ascertainment in several studies may have introduced misclassification of both exposure and outcome, and the restriction to English-language full-text publications may have introduced language and publication biases that could not be formally assessed.

What the analysis does establish, with reasonable confidence, is that diabetic retinopathy deserves attention not merely as an ocular complication but as a potential systemic warning sign. The authors are explicit that the evidence does not establish causality, nor does it demonstrate that routine cognitive screening based solely on retinopathy status improves clinical outcomes. But they argue that future investigations should employ multimodal biomarker approaches, combining amyloid and tau imaging, vascular MRI markers, and quantitative retinal microvascular assessment, to disentangle the relative contributions of vascular and neurodegenerative pathology. If the retina truly is the brain’s most accessible mirror, then the humble eye examination, already a cornerstone of diabetes care, may one day double as an early-warning system for the mind. For now, the message is one of cautious vigilance: the eyes may indeed hold clues to cognitive futures, but the science is still learning how to read them.

Subject of Research: The association between diabetic retinopathy and cognitive impairment or dementia in patients with diabetes mellitus

Article Title: The association between diabetic retinopathy and cognitive impairment in patients with diabetes mellitus: a systematic review and meta-analysis

Article References: Subih, O., Al Mustafa, W. A., AlOmem, T. A., Alrasheed, A. M., Altunaiji, M. S., Alhasan, A. A. M., Alshehri, A. I. A., Alshahrani, B. M., Alharbi, R. J. M., Alshatti, A. M., Al Mutairi, M. E., Alkhaldi, S. M., & Bifari, I. N. (2026). The association between diabetic retinopathy and cognitive impairment in patients with diabetes mellitus: a systematic review and meta-analysis. Frontiers in Endocrinology, 17, Article 1881602. https://doi.org/10.3389/fendo.2026.1881602

Image Credits: AI Generated

DOI: 10.3389/fendo.2026.1881602

Keywords: diabetic retinopathy, dementia, cognitive impairment, Alzheimer's disease, vascular dementia, meta-analysis, systematic review, diabetes mellitus, neurodegeneration, retina, small vessel disease, brain imaging

Researchers at the State University of Campinas in Brazil, working with collaborators in Hungary, Switzerland, France and São Paulo, turned to the Townes HbSS mouse, a humanized model of sickle cell anemia in which the animals carry the same single-point mutation in the beta-globin gene that defines the human disease. That mutation, a substitution of valine for glutamic acid at the sixth codon, causes hemoglobin S to polymerize when deoxygenated, deforming red cells into their characteristic crescent shape. The resulting rigidity and membrane alterations drive hemolysis, endothelial dysfunction, vaso-occlusion and ischemia throughout the body, and the retina, with its exceptionally high metabolic demand, is particularly vulnerable to the consequences.

To confirm that the model faithfully reproduced the human condition, the team first characterized the animals’ blood. Compared with C57BL/6J controls, the Townes HbSS mice showed reductions of roughly 58 percent in erythrocyte count, 52 percent in hematocrit and 46 percent in hemoglobin concentration, alongside dramatic elevations in reticulocytes and white blood cells. Markers of hemolysis told a similar story: total, direct and indirect bilirubin levels were all massively increased, consistent with the ongoing destruction of red cells that characterizes sickle cell anemia. These hematological and metabolic signatures confirmed that the experimental group carried the disease phenotype before any retinal analysis began.

The researchers then probed retinal function using electroretinography, a technique that measures the electrical potentials generated between the cornea and the retina in response to flashes of light of varying intensity. Under dark-adapted conditions, which isolate rod photoreceptor activity, the sickle cell mice produced a-wave amplitudes significantly smaller than controls at the highest light intensity tested, and their implicit times were shortened at an intermediate flash strength. Under light-adapted conditions, which emphasize cone and bipolar cell responses, the b-wave implicit time was prolonged in the diseased animals, indicating a delayed signal in the bipolar cell layer. Perhaps most strikingly, the oscillatory potentials, small rhythmic wavelets superimposed on the b-wave that are thought to reflect inner retinal amacrine cell activity, were reduced in amplitude at maximum light intensity, hinting at early damage to the inner retina before gross structural changes appear.

Histological examination of stained retinal sections reinforced this picture of degeneration. Both the sickle cell mice and the aged controls showed some disorganization of the outer nuclear layer, where photoreceptor cell bodies reside, but the Townes HbSS animals also displayed discrete alterations in the inner nuclear layer, suggesting a pathophysiological process distinct from simple aging. Blood vessels were additionally observed within the ganglion cell layer of the sickle cell retinas, a finding the authors interpret as consistent with the vascular remodeling that accompanies the disease. Because the control strain is known to undergo gradual photoreceptor degeneration beginning around six months of age, the team attributes the inner retinal changes in the sickle cell mice specifically to the vaso-occlusion and hypoxia of the disease rather than to time alone.

The centerpiece of the study, however, is the proteomic analysis. Using label-free quantification on an LTQ Orbitrap Velos mass spectrometer coupled to nanoflow liquid chromatography, the researchers mapped the retinal proteome across pooled samples from five sickle cell mice and seven controls. The analysis identified 2,248 proteins in total, of which 163 were detected exclusively in control retinas and 43 only in the sickle cell group. After applying a nominal significance threshold, 268 proteins emerged as differentially expressed: 63 upregulated and 205 downregulated in the diseased retinas. While no individual protein survived correction for false discovery rate, the pattern of change was far from random, and functional enrichment analysis revealed a coherent molecular story.

Among the downregulated proteins, the most heavily enriched pathways were phototransduction, the citric acid cycle and oxidative phosphorylation, the mitochondrial machinery that generates most of the cell’s ATP. Among the upregulated proteins, the enriched pathways included glycolysis, gluconeogenesis and signaling through hypoxia-inducible factor 1, the master transcriptional regulator of the cellular response to low oxygen. This reciprocal pattern, a collapse of oxygen-dependent energy production paired with an activation of hypoxia-adaptive programs, mirrors what has been observed in other proliferative retinopathies such as retinopathy of prematurity, where independent work has shown that mitochondrial respiration declines at the peak of neovascularization and that supplying metabolic substrates can suppress pathological angiogenesis.

Within the phototransduction pathway, several proteins stood out. The Pde6 family, comprising the alpha, beta and gamma subunits of rod phosphodiesterase, was downregulated, as were Cnga1, the alpha subunit of the cyclic nucleotide-gated channel that carries sodium and calcium into the photoreceptor outer segment, and Slc24a1, a sodium-calcium-potassium exchanger that regulates calcium clearance and photoreceptor recovery after light exposure. Mutations in these same genes are known causes of retinitis pigmentosa and congenital stationary night blindness in humans, disorders characterized by progressive photoreceptor degeneration. To verify that the protein-level findings reflected genuine transcriptional changes, the researchers performed quantitative reverse transcription PCR on selected targets, confirming that both Cnga1 and Slc24a1 messenger RNA were also reduced in the sickle cell retinas, in agreement with the proteomic data.

The convergence of proteomic and transcriptomic evidence on the phototransduction cascade carries particular weight because it suggests that the molecular machinery for converting light into neural signals is being dismantled early in the disease process, before the morphological and functional deficits become pronounced. In a single-cell RNA sequencing study of a retinitis pigmentosa model, downregulation of Pde6g, Cnga1 and Slc24a1 was interpreted as a signature of early rod degeneration that precedes clinical manifestations. The sickle cell retina appears to be following a similar trajectory, driven not by genetic mutation of the photoreceptors themselves but by the hypoxic and ischemic environment created by vaso-occlusion in the microvasculature that supplies them.

The clinical implications are sobering. Current treatments for proliferative sickle cell retinopathy, including laser photocoagulation, intravitreal anti-VEGF injections and vitrectomy for advanced complications, are borrowed from other proliferative retinopathies without dedicated prospective trials in the sickle cell context. While anti-VEGF therapy has shown benefit in regressing seafan vessels and improving vision, recent work in a mouse model of retinal vascular disease found that chronic VEGF inhibition failed to rescue the expression of phototransduction-related genes or prevent photoreceptor loss, raising the possibility that vascular-targeted approaches alone may not address the full spectrum of retinal damage in sickle cell disease. By identifying the metabolic and phototransduction pathways that are compromised before overt structural breakdown, this proteomic study provides a molecular foundation for developing biomarkers that could detect sickle cell retinopathy earlier and for designing mechanism-based therapies that protect photoreceptors directly rather than merely pruning abnormal vessels. The authors acknowledge limitations, including the use of the C57BL/6J strain as controls rather than the ideal Townes HbAA comparator and the absence of retinal flat-mount analysis for angiogenesis quantification, but the molecular landscape they have charted offers a starting point for a field that has long lacked one.

Subject of Research: Proteomic analysis of retinal molecular pathways in a humanized mouse model of sickle cell retinopathy

Article Title: Sickle cell retinopathy molecular investigation through proteomic analysis of Townes HbSS mice retinas

Article References: de Castro, J. N. P., Monte, A. R. C., de Oliveira, A. C. R., Acacio, J. D., Rodrigues, T. A. R., Barboni, M. T. S., Liber, A. M. P., Bonci, D. M. O., Ventura, D. F., Costa, F. F., Camargo, A. C. L., & de Melo, M. B. (2026). Sickle cell retinopathy molecular investigation through proteomic analysis of Townes HbSS mice retinas. Experimental Biology and Medicine, 251, Article 11228. https://doi.org/10.3389/ebm.2026.11228

Image Credits: AI Generated

DOI: 10.3389/ebm.2026.11228

Keywords: sickle cell retinopathy, sickle cell disease, proteomics, Townes HbSS mice, phototransduction, oxidative phosphorylation, hypoxia, retinal degeneration, anti-VEGF, electroretinography, biomarkers, retina

The study, published in Nature Communications by Louise Perez, Lina Shi, and colleagues in the laboratory of Patricia N. Schneider, tackles one of the deepest questions in biology: how complex organs acquire genuinely new capabilities during evolution. The vertebrate eye is often cited as an example of intricate engineering, with its layered neurons, lens, and light-sensitive photoreceptors, and understanding how such a structure can be modified without breaking it is a central challenge for evolutionary developmental biology. Anableps offers an ideal natural experiment, because the species lives its life straddling two optical environments at once. Light behaves very differently in air and in water, bending to different degrees as it enters the eye and carrying different spectral information, so a retina built for underwater vision is not automatically well suited to aerial vision.

To find out what changed in the Anableps eye, the researchers turned to two of the most powerful tools in modern genomics: single-nucleus transcriptomics and spatial transcriptomics. Single-nucleus methods allow scientists to catalog which genes are switched on in thousands of individual cells, revealing the full diversity of cell types present in a tissue. Spatial transcriptomics goes a step further by mapping where those gene-expression profiles sit within the intact organ, preserving the anatomical geography that conventional sequencing destroys. Applied to the Anableps retina, these approaches produced a cell-by-cell, position-by-position atlas of gene activity, letting the team compare the dorsal half of the retina, which handles underwater light, with the ventral half, which handles aerial light.

The atlas delivered a striking first finding: the ventral retina, the region devoted to the aerial view, is developmentally expanded. In a conventional fish eye, the dorsal and ventral halves of the retina are patterned by conserved developmental signals that establish the organ’s top-bottom axis during embryogenesis. In Anableps, the team found that markers of ventral retinal identity are overrepresented, and comparative spatial profiling of developing and adult Anableps alongside the killifish, a related surface-dwelling species with an ordinary single-vision eye, showed that the boundary separating the dorsal and ventral territories has shifted toward the dorsal side. The result is a proportionally larger ventral domain. In other words, evolution did not build a new compartment in the eye; it redrew the existing map, enlarging the aerial-vision territory at the expense of the aquatic one.

The second major finding concerns the photoreceptors themselves, the cone cells that provide color vision in bright light. Cones owe their spectral sensitivity to light-absorbing proteins called opsins, and the wavelength each opsin absorbs best is determined by its amino acid sequence. Fish genomes typically harbor multiple opsin genes, or paralogs, that arose through ancient duplications, and different copies can be tuned to different parts of the light spectrum. The spatial transcriptomic data revealed that opsin expression in Anableps is regionally organized within a single cone subtype. Cones in the ventral, aerial-vision region of the retina, designated PR1 cones, express a gene called opn1mw2, whereas the corresponding cones in the dorsal, underwater region express the longer-wavelength-sensitive opn1lw paralogs.

That regional swap matters because the two optical environments demand different sensitivities. To estimate how the proteins actually perform, the researchers used machine-learning predictions of opsin spectral properties. These analyses indicated that the Opn1mw2 pigment found in the ventral cones is red-shifted relative to Opn1mw1, another member of the medium-wavelength-sensitive opsin family, but remains blue-shifted relative to the dorsal Opn1lw pigments. The ventral retina therefore occupies an intermediate spectral position: tuned differently from the dorsal retina, and presumably better matched to the quality of light arriving from above the surface, yet still drawing on the same family of cone pigments that ancestral fishes used. The adaptation is a reshuffling of existing genetic resources, not the appearance of an entirely new photoreceptor class.

Taken together, the results sketch a coherent evolutionary pathway. Anableps did not need to evolve novel genes or novel cell types to peer into the air. Instead, it co-opted the developmental machinery that already patterns the dorsal-ventral axis of the vertebrate retina, shifting the boundary between territories so that the ventral domain grew larger, and then rewired the opsin expression programs of conserved cone subtypes so that each half of the retina is tuned to its own light environment. This kind of remodeling, in which ancient developmental circuits are redeployed to produce new proportions and new regional specializations, is increasingly recognized as a common route to evolutionary novelty, particularly in organs as complex and constrained as the eye.

The study also highlights how non-model organisms can illuminate questions that laboratory staples cannot. Anableps is not a traditional genetic model like the zebrafish or the mouse, but its unusual lifestyle makes it uniquely informative about sensory adaptation. By pairing modern transcriptomic techniques with careful comparisons against a related fish with conventional vision, the researchers could distinguish what is genuinely unusual about the Anableps retina from what is shared across teleosts. The finding that dorsal-ventral patterning markers reveal an expanded ventral identity, corroborated by the spatial comparison with killifish at both developmental and adult stages, gives the conclusion a firm anatomical footing rather than resting on gene-expression differences alone.

For the four-eyed fish itself, the payoff is a life lived at the interface. Cruising the surface with half of each eye in each world, Anableps can scan for insects and predators in the air while simultaneously watching for threats and prey below, a capability that depends on a retina partitioned into two spectrally and developmentally distinct zones. The new work shows that this partition is written into the organ’s developmental blueprint and into the pigment choices of its cone cells. It is a vivid reminder that evolution is often a tinkerer rather than an inventor, achieving dramatic functional change by enlarging, shifting, and reprogramming the parts it already has.

The research, funded by start-up funds from Louisiana State University and a grant from the National Science Foundation’s Integrative Organismal Systems program, was published as an open-access article, making the full dataset and methods available to other teams studying retinal evolution and sensory ecology. As spatial and single-cell technologies continue to spread beyond traditional model species, eyes like those of Anableps are likely to yield further secrets about how vertebrate sensory organs adapt to the world’s many light environments, one developmental tweak at a time.

Subject of Research: Evolutionary remodeling of the ventral retina enabling simultaneous aerial and aquatic vision in the four-eyed fish Anableps anableps

Article Title: Evolutionary remodeling of the ventral retina enables aerial vision in the four-eyed fish Anableps anableps

Article References: Perez, L., Shi, L., Daspit, A., Pruett, K. N., Smith, C., Prideaux, A., Sousa, J. F., & Schneider, P. N. (2026). Evolutionary remodeling of the ventral retina enables aerial vision in the four-eyed fish Anableps anableps. Nature Communications. https://doi.org/10.1038/s41467-026-78775-4

Image Credits: AI Generated

DOI: 10.1038/s41467-026-78775-4

Keywords: four-eyed fish, Anableps anableps, retina, evolutionary developmental biology, opsins, spatial transcriptomics, single-nucleus transcriptomics, photoreceptors, aerial vision, dorsal-ventral patterning, non-model organisms, Nature Communications

The study, whose full title is “Transcriptomic analyses link changes in gene expression to defects in pigment cell differentiation and eye morphogenesis in a zebrafish model for Oculocutaneous Albinism Type 2,” was published on 7 August 2026 and carries the DOI 10.1016/j.ydbio.2026.07.011. In it, Cooper and her colleagues examined zebrafish embryos carrying a mutation in the fish version of the OCA2 gene and tracked how pigment cells and the eyes formed compared with embryos lacking the mutation. What they found was not simply a loss of color. Instead, the mutation produced unexpected changes in the number and location of specialized pigment cells, altered the timing of key events in eye formation, and shifted the activity of dozens of other genes across the developing embryo.

OCA2 is best known as one of the principal genes implicated in oculocutaneous albinism, a condition that affects an estimated one in 17,000 people worldwide, though prevalence varies considerably among populations. The gene encodes a protein involved in the regulation of melanin production, and disruptions to it reduce or eliminate pigmentation in the skin, hair and eyes. For decades, the clinical features of albinism have been understood primarily through the lens of pigment deficiency. Yet the defining burden of the condition for many patients is not the loss of color itself but the vision problems that accompany it, including reduced visual acuity and involuntary eye movements known as nystagmus, which can create lifelong challenges with everyday activities such as reading and driving.

It is precisely this gap between pigment biology and visual pathology that the WSU team set out to explore. “We’re interested in understanding processes that you wouldn’t necessarily expect to depend on melanin, but it turns out they do,” said Cooper, the study’s corresponding author. “It’s another surprising mechanism that cells are using to develop correctly.” Her comment captures the central surprise of the work: a gene conventionally cast as a pigment regulator appears to participate in developmental programs that govern how tissues, including the eye, take shape.

The choice of zebrafish as the experimental platform was no accident. Like humans, zebrafish are vertebrates and deploy many of the same genes to produce pigment cells, making them a genetically relevant model for studying pigmentation disorders. Their embryos are transparent and develop rapidly outside the body, allowing researchers to observe, in real time and under the microscope, biological changes that would be extraordinarily difficult to capture in mammalian or human development. Cooper has worked with the fish for more than twenty years, and the species has an established track record in studies ranging from heart development to neurological disorders and cancer.

For the new study, the researchers examined embryos carrying the OCA2 mutation and followed two threads of investigation in parallel. The first was observational: they tracked how pigment cells and the eyes developed in the mutant embryos. The second was molecular: they compared gene activity, or transcriptomic profiles, between embryos with the mutation and embryos without it, using the differences to identify which genetic programs were disrupted. This combination of direct developmental observation with genome-wide expression analysis is what allowed the team to connect visible defects to underlying changes in gene regulation.

One of the most striking observations involved iridophores, a class of reflective pigment cells found in fish and amphibians that give zebrafish their characteristic silvery and iridescent stripes. The mutant embryos showed unexpected differences in both the number and the location of these cells. Humans do not possess iridophores, but the cells arise from the neural crest, a transient embryonic tissue that in humans also gives rise to a wide array of cell types, including parts of the peripheral nervous system, facial structures and other pigment cells. That shared developmental origin makes iridophores a valuable window into how a mutation in a pigment-related gene can ripple outward and affect cell differentiation more generally, even in lineages that do not exist in our own species.

The developing eyes told a parallel story of disruption. In the mutant embryos, a temporary opening in the embryonic eye, a normal feature of early development that must close for the eye to form properly, took longer than usual to seal. Meanwhile, cells in the retina developed and organized differently than in their unaffected counterparts. These defects in eye morphogenesis are particularly intriguing given that structural abnormalities of the eye, including defects in the way retinal cells are organized and routed to the brain, are central to the visual impairment seen in people with albinism. The zebrafish data suggest that OCA2 may be connected to these processes in ways that go beyond simply supplying melanin to the developing tissue.

The transcriptomic comparison reinforced that impression. When the researchers contrasted gene activity in embryos with and without the mutation, they identified changes in dozens of genes, including many that help cells determine what they will become and that guide the formation of the eyes and other tissues. In other words, perturbing OCA2 did not merely silence a pigment pathway; it appeared to reconfigure regulatory networks involved in cell fate decisions and organ formation. The authors’ use of the term “transcriptomic analyses” in the article title reflects this genome-scale approach, which treats the mutation’s effects as a system-wide shift in gene expression rather than a single broken link in a linear pathway.

The researchers are careful to note that the findings cannot yet be assumed to apply directly to people. Zebrafish biology, while broadly conserved with ours, differs in important respects, and iridophores in particular have no direct human equivalent. Cooper said the next steps will be to determine where, when and why the altered gene activity occurs, and then to look for similar effects in mammals and, eventually, in human cells. Establishing that the same developmental programs are affected in human embryos or patient-derived cells would be a critical step toward translating the zebrafish observations into clinically relevant knowledge.

If those connections hold, the implications could be significant. By revealing more about how albinism-related mutations affect development, the research could eventually help identify possible treatment targets for the vision complications associated with the condition, which currently have limited therapeutic options. A clearer understanding of how cells normally develop and organize themselves, and of what happens when that process goes awry, could also inform research into other diseases, Cooper noted, including cancer, in which cells fail to develop or behave normally. In that sense, a gene studied through the stripes of a small fish may illuminate fundamental principles of cell biology that extend well beyond pigmentation.

The project also carried an educational dimension that its authors regard as integral to the work. Co-authors J. Rionach McCarthy and Samuel Vernon were undergraduates when they conducted their experiments, continuing a tradition in Cooper’s laboratory that has helped prepare roughly sixty students for careers in medicine, pharmacy and research. The combination of a clinically motivated question, a transparent and tractable model organism, and hands-on training for early-career scientists reflects a model of research in which discovery and mentorship advance together.

For now, the immediate question driving the laboratory forward is mechanistic. “We’re just trying to figure out what it is about this gene that is causing changes to the activation of genes in neighboring cells,” Cooper said. “That’s what we’re up to next.” Answering that question, whether OCA2 acts through melanin-dependent signaling, through some independent function of its protein, or through indirect effects on cell interactions within the developing tissue, will determine how the zebrafish findings map onto human biology. What the study already establishes is that a gene long defined by the color it fails to produce is entangled in a much larger web of developmental control, one whose threads may run all the way to the visual difficulties experienced by people with albinism around the world.

Subject of Research: The role of the OCA2 albinism gene in pigment cell differentiation and eye development using a zebrafish model

Article Title: Zebrafish reveal wider role for gene linked to human albinism

Article References: Zebrafish reveal wider role for gene linked to human albinism. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: zebrafish, OCA2, albinism, developmental biology, pigment cells, iridophores, eye development, transcriptomics, gene expression, melanin, retina, Washington State University

The study, published in Cell Death Discovery by Lijun Zhang, Yan Li, and colleagues at Shandong Second Medical University, focuses on metallothionein 3, a small protein with a remarkable capacity to bind metal ions. The researchers set out to determine whether MT3 influences the development of RIRI by regulating a copper transport pathway known as the Atox1–ATP7a axis, thereby modulating cuproptosis, a form of regulated cell death that was only identified in recent years and had not previously been fully characterized in the context of retinal injury. The work combines transcriptomic sequencing, bioinformatic analysis, a rat model of retinal ischemia–reperfusion, cell culture experiments, recombinant protein rescue studies, and a battery of complementary molecular assays.

Cuproptosis entered the scientific vocabulary only recently, and its discovery reshaped how researchers think about metal-mediated cell death. Unlike apoptosis, necroptosis, or ferroptosis, cuproptosis depends directly on copper ions. In the canonical model, excess copper binds to lipid-acylated components of the mitochondrial tricarboxylic acid cycle, causing those proteins to aggregate. The result is a collapse of mitochondrial function, proteotoxic stress, and ultimately cell death. Because copper is an essential trace element that participates in respiration, antioxidant defense, and enzyme catalysis, cells must maintain it within narrow limits. Too little copper cripples metabolism; too much triggers the lethal aggregation that defines cuproptosis. Understanding how cells manage this delicate balance during disease has become a rapidly growing field.

The copper transport machinery at the center of the new study is a two-part system. Atox1, short for antioxidant 1 copper chaperone, is a small protein that ferries copper ions through the cell’s interior, delivering them to ATP7a, a copper-transporting adenosine triphosphatase embedded in cellular membranes. ATP7a then pumps copper out of the cell or routes it to copper-dependent enzymes. Together, this axis acts as a controlled export pathway, a molecular pump-and-chaperone system that keeps intracellular copper from accumulating to dangerous levels. When the axis falters, copper ions that should be expelled remain inside the cell, where they can participate in the protein aggregation and mitochondrial damage characteristic of cuproptosis.

Using their rat model of retinal ischemia–reperfusion injury, the researchers gathered evidence that cuproptosis occurs in retinal ganglion cells following RIRI. Retinal ganglion cells are the neurons whose long axons form the optic nerve, carrying visual signals from the eye to the brain. Their loss is irreversible, which is why ganglion cell death is the decisive event in glaucoma and many other blinding diseases. Demonstrating that this specific, copper-dependent death program operates in ganglion cells after ischemia–reperfusion adds an important new dimension to the cell death landscape of the retina, which researchers had previously mapped largely in terms of apoptosis and other better-studied pathways.

But the most striking finding concerned a different cell type. The researchers found that MT3 expression was markedly downregulated in retinal Müller cells, the glial cells that span the entire thickness of the retina and provide structural, metabolic, and homeostatic support to neurons. Müller cells are the workhorses of retinal maintenance: they regulate the chemical environment of the retina, buffer neurotransmitters, and help manage water and ion balance. The team found that this downregulation of MT3 was associated with impaired function of the Atox1–ATP7a copper transport axis, decreased copper ion efflux, and enhanced cuproptosis-related injury in Müller cells, ultimately exacerbating retinal damage. In other words, when MT3 levels fell, the copper export machinery weakened, copper accumulated, and the glial cells that support the retina suffered copper-driven injury.

To test whether this relationship was causal rather than merely correlational, the researchers turned to rescue experiments using recombinant MT3 protein. By supplying the protein experimentally, they could ask whether restoring MT3 function would protect cells from the cascade of copper accumulation and cuproptosis-related damage. Combined with their R28 retinal cell culture system and complementary molecular assays, these experiments allowed the team to build a mechanistic chain linking MT3, the Atox1–ATP7a axis, copper efflux, and cell survival. The study thereby explains, in mechanistic depth, how MT3 regulates cuproptosis through the Atox1–ATP7a axis in retinal ischemia–reperfusion injury.

The technical approach behind these conclusions reflects the modern toolkit of cell death research. Transcriptomic sequencing allowed the team to survey gene expression across the retina after injury, and bioinformatic analysis helped identify MT3 as a candidate regulator within the copper-handling network. The rat RIRI model, in which blood flow to the retina is temporarily interrupted and then restored, reproduces the ischemia–reperfusion conditions relevant to human ocular disease. R28 cells, a retinal precursor-derived cell line, provided a controlled in vitro environment for molecular manipulation, while recombinant MT3 protein enabled rescue experiments that tested the pathway’s function directly. Together, these complementary approaches strengthen the evidence that the MT3–Atox1–ATP7a–cuproptosis axis is a genuine regulatory circuit rather than an incidental association.

The clinical implications are significant. Because effective targeted therapeutic approaches for RIRI remain limited, the identification of MT3 as a regulator of copper-dependent injury suggests a promising novel therapeutic target. If MT3 levels could be preserved or restored in the retina after ischemic events, the copper export machinery might continue functioning, limiting cuproptosis-related damage to Müller cells and, by extension, reducing the secondary injury that spreads to vulnerable retinal ganglion cells. Such a strategy would represent a departure from current approaches that focus on lowering intraocular pressure or broadly suppressing inflammation, instead intervening at the level of a specific regulated cell death program and its metal-handling machinery.

The study also adds to a broader shift in biomedical science, in which cell death is understood not as a single failure mode but as a family of precisely regulated programs, each with its own triggers, molecular machinery, and therapeutic vulnerabilities. Copper, long appreciated mainly as an essential nutrient, has now been implicated as an active executioner in the retina under ischemic stress, with a specific chaperone-and-pump system serving as the gatekeeper. As researchers continue to map the roles of cuproptosis across tissues and diseases, the retina joins the growing list of organs in which metal ion homeostasis may prove to be the difference between recovery and irreversible damage. For the millions of people at risk of vision loss from retinal ischemia, that distinction could one day translate into new treatments built on a small copper-binding protein and the transport axis it controls.

Subject of Research: Regulation of cuproptosis by metallothionein 3 via the Atox1–ATP7a copper transport axis in retinal ischemia–reperfusion injury

Article Title: Metallothionein 3 regulates cuproptosis in rat retinal ischemia-reperfusion injury via the Atox1–ATP7a axis

Article References: Zhang, L., Li, Y., Liu, Z., Yu, F., Luo, J., Ci, R., Wang, X., & Zhao, Y. (2026). Metallothionein 3 regulates cuproptosis in rat retinal ischemia-reperfusion injury via the Atox1–ATP7a axis. Cell Death Discovery. https://doi.org/10.1038/s41420-026-03386-3

Image Credits: AI Generated

DOI: 10.1038/s41420-026-03386-3

Keywords: cuproptosis, metallothionein 3, retinal ischemia-reperfusion injury, Atox1, ATP7a, copper transport, retinal ganglion cells, Müller cells, cell death, retina, neuroprotection, glaucoma

Now a study led by Dr. David S. Williams, professor of ophthalmology and neurobiology at the David Geffen School of Medicine at UCLA, in collaboration with researchers at the University of California, Santa Barbara and Harvard, reports that the answer for primates is the opposite of what is seen in many other vertebrates. Working with retinal tissue near the fovea of Rhesus monkeys (Macaca mulatta), the team found that the majority of disk membranes in primate cones are closed, self-contained structures, much like the disks found in rod photoreceptors, the cells responsible for vision in dim light. The work, published in the Journal of Neuroscience, represents the first quantitative assessment of the relative proportion of open and closed disk membranes in a mammalian cone, and it settles a debate that has lingered since the earliest electron micrographs of the retina were first interpreted.

The significance of the question is easier to appreciate when one considers what the disks actually do. Phototransduction, the molecular cascade that turns a single photon into an electrical signal, takes place on these membranes. Light-sensitive opsin proteins and the G protein transducin are embedded in the disk membrane, and the second messenger cyclic GMP, along with calcium ions, diffuses in the compartments defined by the disk geometry. Whether the interior of a disk communicates freely with the space outside the cell or is sealed off changes the diffusion pathways available to these signaling molecules, the surface area available for protein trafficking, and the way in which the cell renews its light-sensitive machinery. Structure, in other words, is not a cosmetic detail; it constrains the entire operating logic of the photoreceptor.

Historically, the debate arose because different experimental approaches yielded apparently conflicting pictures. Early transmission electron microscopy of retinal sections produced images that some investigators interpreted as showing continuity between the disk rim and the plasma membrane, while others saw sealed, independent sacs. Preparation artifacts, the extreme fragility of photoreceptor outer segments, and the sheer difficulty of cutting and imaging tissue thin enough to resolve the relevant membranes all conspired to keep the question open. In non-mammalian cones, serial sectioning and physiological measurements converged on the conclusion that the disks are generally open, continuous evaginations of the plasma membrane, and many researchers assumed that mammalian cones would follow the same plan. Without quantitative data from primate tissue, however, the assumption remained exactly that: an assumption.

The UCLA-led team attacked the problem with two independent methods, each capable of addressing the question from a different direction. The first was electron tomography, a technique that goes beyond conventional two-dimensional electron micrographs by reconstructing three-dimensional volumes of tissue from a series of images taken at different tilt angles. Rather than inferring membrane topology from a single thin slice, tomography allows investigators to trace membranes through the volume and determine whether a given disk is sealed or whether it opens onto the extracellular space. Applied to the cone outer segments of the foveal region in Rhesus monkey retina, this approach provided direct structural evidence about the patency, or openness, of individual disk membranes.

The second approach was electrophysiological. If cone disks were open to the extracellular space, the electrical properties of the cell would reflect that continuity in measurable ways, because the membrane area accessible to ion channels and to the diffusion of charged signaling molecules would be organized differently than in a cell with sealed disks. By recording from primate cone photoreceptors and analyzing the electrical signatures of the outer segment, the researchers obtained functional evidence that could be compared directly against the structural data. The power of the study lies in this convergence: two methods with entirely different sources of potential error pointed to the same conclusion, and that conclusion contradicted the pattern established in non-mammalian vertebrates.

Through both approaches, the researchers found that the majority of disk membranes in primate cones are closed, independent structures. This is the configuration familiar from rod photoreceptors, whose disks are well established to be enclosed sacs that are periodically shed at the tip of the outer segment and renewed through new membrane synthesis at the base. The finding means that primate cones, despite their distinct morphology and their role in high-acuity color vision, share with rods the fundamental design principle of sealed disk membranes. It also means that textbooks and models of cone function, many of which have implicitly carried the open-disk assumption into discussions of mammalian and human vision, will need to be revised.

The implications extend into several areas of cell biology and physiology. Disk membrane renewal is one of the most remarkable housekeeping operations in the body: photoreceptors constantly rebuild their light-sensitive stacks, and in rods this involves the daily shedding and phagocytosis of aged disk packets by the retinal pigment epithelium. Whether cones renew their disks through a comparable process has been debated in its own right, and the closed architecture documented in this study provides a structural framework for understanding how such renewal could proceed in primate cones. Similarly, models of phototransduction depend on assumptions about the compartments in which cyclic GMP and calcium diffuse; sealed disks create a distinct intradiskal space whose ionic composition can be regulated separately from the extracellular environment, altering the dynamics of adaptation, the process by which photoreceptors adjust their sensitivity across enormous ranges of light intensity.

Because the tissue examined came from the region near the fovea, the part of the primate retina responsible for our sharpest, most detailed vision, the findings speak directly to human visual physiology. The Rhesus macaque is a well-established model for human retinal structure and function, and the cone-dominant foveal region is precisely where the stakes of the structural question are highest. Understanding that the disks in these cells are closed brings the structural biology of primate cones into alignment with the electrophysiological models that have been refined over decades, and it offers a corrected foundation for studying retinal diseases that target cones, including the macular degenerations that rob millions of people of central vision. The authors declare no competing financial interests, and the research was published as a peer-reviewed contribution to the Journal of Neuroscience under the title describing the ultrastructural and electrophysiological determination of monkey cone outer segment membrane patency.

What makes the study a striking example of basic science at its best is that it resolves, with modern tools, a question posed at the dawn of retinal ultrastructure. The combination of three-dimensional electron tomography with complementary electrophysiology provided the quantitative rigor that earlier generations of microscopists could not achieve, and the answer it delivered, that primate cone disks are closed like those of rods, reshapes how scientists will model phototransduction, disk renewal, and cone physiology in humans. After sixty years of uncertainty, the architecture of the cells that give primates their remarkable color vision is finally clear, and that clarity opens the door to a deeper understanding of how the eye builds sight from stacks of membrane only nanometers thick.

Subject of Research: Structural patency of disk membranes in primate cone photoreceptors

Article Title: Study from the Stein Eye Institute answers long-debated structural question of primate cone photoreceptors

Article References: Study from the Stein Eye Institute answers long-debated structural question of primate cone photoreceptors. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: cone photoreceptors, retina, disk membranes, electron tomography, electrophysiology, phototransduction, Rhesus macaque, fovea, vision science, UCLA, Journal of Neuroscience, photoreceptor structure

The brain care score, developed at the McCance Center for Brain Health, condenses twelve modifiable factors into a single number: four physical measures (blood pressure, hemoglobin A1c, cholesterol, and body mass index), five lifestyle behaviors (nutrition, alcohol intake, smoking, physical activity, and sleep), and three social-emotional dimensions (stress, relationships, and meaning in life). In the UK Biobank adaptation used here, the score ranges up to 19 points, with higher values indicating better brain care. Previous studies have linked higher scores to favorable neuroimaging markers and reduced risks of dementia, stroke, and late-life depression. What remained unknown was whether the score also tracks with the fine-grained architecture of the retina, an outgrowth of the central nervous system that shares vascular, metabolic, and inflammatory biology with the brain.

To find out, the team led by investigators at The Chinese University of Hong Kong analyzed optical coherence tomography (OCT) scans from 28,657 UK Biobank participants aged 40 to 69. OCT is a non-invasive imaging technique that uses light interference to map retinal layers at micrometer resolution, and the researchers examined eight distinct layers plus overall macular thickness. After rigorous quality control and statistical adjustment for age, sex, ethnicity, education, deprivation, cardiovascular disease history, refractive error, and intraocular pressure, a clear pattern emerged: each 5-point increase in the brain care score was associated with thicker retinal nerve fiber layer, thicker ganglion cell–inner plexiform layer, thicker photoreceptor segments, and greater average macular thickness.

The effect sizes are small in absolute terms—a few tenths of a micrometer per 5-point score increase, translating to roughly 1.2 percent difference in nerve fiber layer thickness and about half a percent for the ganglion cell layer relative to cohort means. The researchers are careful to stress that these are population-level structural differences, not differences an ophthalmologist could detect in a single patient or act on clinically. Yet the pattern was remarkably consistent. Participants in the lowest score quartile had significantly thinner layers across the board compared with those in the highest quartile, all trend tests were highly significant, and the findings held up in sensitivity analyses that accounted for nonlinear aging effects, restricted the sample to European participants, and replicated the associations using repeat OCT visits years later.

Perhaps the most provocative result concerns retinal biological age. The team trained a support vector machine on 60 OCT-derived structural metrics from thousands of healthy participants to predict chronological age from retinal structure alone, then defined an OCT age gap as the bias-corrected predicted age minus actual age. Positive values indicate a retina that looks older than it should. After full adjustment, each 5-point increase in brain care score was associated with a 0.326-year reduction in this retinal age gap, with the mean gap falling progressively from 0.39 years in the lowest score quartile to −0.08 years in the highest. In other words, people who take better care of their brains carry retinas that read as younger on a machine-learning clock.

Dissecting the score into its components revealed where the signal lives. The physical and lifestyle domains drove the associations, while the social-emotional domain showed no independent link to retinal structure. Favorable blood pressure, hemoglobin A1c, and body mass index were each tied to thicker specific layers and a smaller retinal age gap, with effects on the age gap ranging from about a quarter to nearly half a year. Non-smoking, moderate alcohol intake, regular aerobic exercise, and at least seven hours of nightly sleep each contributed modest reductions in retinal biological age. Interestingly, total cholesterol below 190 milligrams per deciliter was actually associated with a slightly larger retinal age gap, echoing a growing literature on the complex, sometimes U-shaped relationships between lipids and neurological health.

To probe the biology behind these correlations, the researchers turned to metabolomics. For a subset of 14,656 participants with nuclear magnetic resonance profiling of 249 plasma biomarkers, they ran exploratory mediation analyses asking whether circulating metabolites statistically carry part of the association between brain care score and retinal thickness. The candidate pathways that emerged centered on lipid metabolism, unsaturated fatty acids, and branched-chain amino acids. One principal component reflecting HDL-enriched lipid profiles mediated a small fraction of the association with nerve fiber and ganglion cell layer thickness, while another dominated by omega-3 polyunsaturated fatty acids showed positive indirect effects on photoreceptor layer thickness—a plausible finding given that docosahexaenoic acid, the dominant long-chain fatty acid in photoreceptor outer-segment membranes, is essential for photoreceptor function.

The authors are appropriately cautious about these mediation results. Because the brain care score, the metabolites, and the retinal measurements were all captured at the same point in time, no temporal ordering can be established, and the indirect-effect estimates cannot confirm genuine biological causation. The principal components themselves may be sample-dependent, and the proportion of the total effect explained by any single metabolic pattern was modest—ranging from under 3 percent to about 11 percent. Still, the convergence on lipid and amino acid pathways is biologically coherent: excess branched-chain amino acids have been implicated in oxidative stress and inflammation in animal models of diabetic retinopathy, and lipoprotein subclass composition has repeatedly surfaced in studies of age-related macular degeneration.

The broader significance of the study lies in what it says about the retina as a sentinel organ. Thinner retinal nerve fiber and ganglion cell layers have previously been linked to cognitive decline, reduced brain volumes, Alzheimer’s disease, and incident dementia, and photoreceptor thinning has been associated with morbidity and mortality. By showing that a practical, modifiable brain health index tracks with both retinal structure and a machine-learned retinal age, the findings reinforce the idea that the same vascular and metabolic forces that shape brain aging also leave fingerprints in the eye—fingerprints that a routine OCT scan, already common in eye clinics, can capture.

Limitations remain, and the researchers enumerate them candidly. The observational design leaves room for residual confounding, the cohort’s healthier-than-average volunteers and predominantly European ancestry may limit generalizability, and the OCT-based age clock correlates only moderately with chronological age, meaning it captures just one facet of retinal aging. The brain care score itself is still a prototype awaiting systematic refinement. What the study delivers is a hypothesis-generating map: a demonstration that brain care and retinal health travel together, that specific metabolic pathways plausibly connect them, and that longitudinal studies with repeated measurements should now test whether improving one’s brain care score actually slows the thinning of the retina—and, by extension, perhaps the aging of the brain behind it.

Subject of Research: Associations between the brain care score and retinal layer thickness and retinal biological age in the UK Biobank

Article Title: Brain care score and retinal health: structural and metabolic insights from the UK Biobank

Article References: Yu, J., Zhang, Y., Gao, Y. L., Ho, M., Kam, K. W., Gong, B., Young, A. L., Pang, C. P., Tham, C. C., Yam, J. C., & Chen, L. J. (2026). Brain care score and retinal health: structural and metabolic insights from the UK Biobank. GeroScience. https://doi.org/10.1007/s11357-026-02579-z

Image Credits: AI Generated

DOI: 10.1007/s11357-026-02579-z

Keywords: brain care score, retina, optical coherence tomography, UK Biobank, retinal biological age, metabolomics, macular thickness, neurodegeneration, lipid metabolism, omega-3 fatty acids, GeroScience, brain health